MedPath
HSA Approval

MYOPHIL FILM COATED TABLETS 20MG

SIN17176P

MYOPHIL FILM COATED TABLETS 20MG

MYOPHIL FILM COATED TABLETS 20MG

February 10, 2025

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L01EA02

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

Biocon Pharma Limited

Active Ingredients

Dasatinib monohydrate eqv Dasatinib

20mg

Dasatinib

Documents

Package Inserts

Myophil Tablet PI.pdf

Approved: March 12, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MYOPHIL FILM COATED TABLETS 20MG - HSA Approval | MedPath